Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Thomas Jefferson University
NRG Oncology
University of Washington
City of Hope Medical Center
Mayo Clinic
Mayo Clinic
NRG Oncology
Northwestern University